BRD2 and metabolic syndrome: Further larger clinical and experimental studies aimed to reveal the mechanism underlying the effects of FSH on energy metabolism, including fat and glucose metabolism and identify the potential of FSH as a biomarker of the risk of MetS and CVD, are needed.